Increased HIF-1α expression in tumor biopsies is associated with BC patient mortality, and HIFs activate the expression of gene products that mediate angiogenesis, cancer stem cell specification, epithelial-mesenchymal transition, glucose and lipid metabolism, immune evasion, invasion, and metastasis (37–39). The gene discussed is HIF1A; the disease is cancer.